ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

Cancer Pain Treatment Guide Published By NCCN, ACS

April 27, 2001

NCI-Approved Clinical Trials

July 29, 2005

FCRF Program Proving Good Basic Research Can Be Supported By NCI With a Contract

January 23, 1987

Combination Skin Treatments Reduce Rash From Vectibix

June 26, 2009

In Brief: James Wallace Named CALGB Executive Officer; Gritz Receives First Joseph Cullen Award

September 11, 1992

Gene Expression Analyses Can Guide MDS Treatments

December 30, 2011